SynthesisBMC cancer2021

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis.

Xinxin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.